Evidence map›Paper›PMID 27556514›Full record

ArticleOncotarget2016

ROCK inhibitor reduces Myc-induced apoptosis and mediates immortalization of human keratinocytes.

Aleksandra Dakic, Kyle DiVito, Shuang Fang, Frank Suprynowicz, Anirudh Gaur, Xin Li, Nancy Palechor-Ceron, Vera Simic, Sujata Choudhury, Songtao Yu and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Rho Kinases in Embryonic Development and Stem Cell Research.Archivum immunologiae et therapiae experimentalis · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. An overview of neuroblastoma cell lineage phenotypes andExperimental biology and medicine (Maywood, N.J.) · 2020
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Aleksandra DakicDepartment of Pathology, Georgetown University Medical School, Washington, DC 20057, USA.
Kyle DiVitoDepartment of Molecular and Cell Biology and Biochemistry, Georgetown University Medical School, Washington, DC 20057, USA.
Shuang FangDepartment of Pathology, Georgetown University Medical School, Washington, DC 20057, USA.
Frank SuprynowiczDepartment of Pathology, Georgetown University Medical School, Washington, DC 20057, USA.
Anirudh GaurDepartment of Molecular and Cell Biology and Biochemistry, Georgetown University Medical School, Washington, DC 20057, USA.
Xin LiDepartment of Biostatistics, Bioinformatics, Georgetown University Medical School, Washington, DC 20057, USA.
Nancy Palechor-CeronDepartment of Pathology, Georgetown University Medical School, Washington, DC 20057, USA.
Vera SimicDepartment of Pathology, Georgetown University Medical School, Washington, DC 20057, USA.
Sujata ChoudhuryDepartment of Pathology, Georgetown University Medical School, Washington, DC 20057, USA.
Songtao YuDepartment of Pathology, Georgetown University Medical School, Washington, DC 20057, USA.
Cynthia M Simbulan-RosenthalDepartment of Molecular and Cell Biology and Biochemistry, Georgetown University Medical School, Washington, DC 20057, USA.
Dean RosenthalDepartment of Molecular and Cell Biology and Biochemistry, Georgetown University Medical School, Washington, DC 20057, USA.
Richard SchlegelDepartment of Pathology, Georgetown University Medical School, Washington, DC 20057, USA.
Xuefeng LiuDepartment of Pathology, Georgetown University Medical School, Washington, DC 20057, USA.
Georgetown University · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI STEPHEN W BYERS · 1990 to 2026
$71.5M
Conditionally reprogrammed cells as a novel tool for biobankingR33CA177466 · NCI · GEORGETOWN UNIVERSITY · PI SCHLEGEL, RICHARD, WELLSTEIN, ANTON · 2013 to 2015
$1.2M
NON-CANONICAL FUNCTIONS OF HTERT IN CELL IMMORTALIZATION BY HPVR21CA180524 · NCI · GEORGETOWN UNIVERSITY · PI LIU, XUEFENG · 2013 to 2014
$366k
NCI NIH HHS P30 CA051008NCI NIH HHS R21 CA180524NCI NIH HHS R33 CA177466
6 · The paper itself

Abstract

The Myc/Max/Mad network plays a critical role in cell proliferation, differentiation and apoptosis and c-Myc is overexpressed in many cancers, including HPV-positive cervical cancer cell lines. Despite the tolerance of cervical cancer keratinocytes to high Myc expression, we found that the solitary transduction of the Myc gene into primary cervical and foreskin keratinocytes induced rapid cell death. These findings suggested that the anti-apoptotic activity of E7 in cervical cancer cells might be responsible for negating the apoptotic activity of over-expressed Myc. Indeed, our earlier in vitro studies demonstrated that Myc and E7 synergize in the immortalization of keratinocytes. Since we previously postulated that E7 and the ROCK inhibitor, Y-27632, were members of the same functional pathway in cell immortalization, we tested whether Y-27632 would inhibit apoptosis induced by the over-expression of Myc. Our findings indicate that Y-27632 rapidly inhibited Myc-induced membrane blebbing and cellular apoptosis and, more generally, functioned as an inhibitor of extrinsic and intrinsic pathways of cell death. Most important, Y-27632 cooperated with Myc to immortalize keratinocytes efficiently, indicating that apoptosis is a major barrier to Myc-induced immortalization of keratinocytes. The anti-apoptotic activity of Y-27632 correlated with a reduction in p53 serine 15 phosphorylation and the consequent reduction in the expression of downstream target genes p21 and DAPK1, two genes involved in the induction of cell death.

Indexed as

AmidesApoptosisCells, CulturedCell Transformation, ViralCyclin-Dependent Kinase Inhibitor p21Death-Associated Protein KinasesEnzyme InhibitorsGene Expression ProfilingHumansKeratinocytesMalePhosphorylationProto-Oncogene Proteins c-mycPyridinesrho-Associated KinasesTumor Suppressor Protein p53AmidesCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21DAPK1 protein, humanDeath-Associated Protein KinasesEnzyme InhibitorsProto-Oncogene Proteins c-mycPyridinesrho-Associated KinasesTumor Suppressor Protein p53Y 27632apoptosiscytoskeletonMycROCKtelomerase

Identifiers

PMID27556514
PMCPMC5341834
OpenAlexW2511705710

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.